Eli Lilly puts obesity field
Digest more
Zealand Pharma plans to launch five obesity and related drugs by 2030 as the Danish company tries to break into the lucrative ...
Visceral obesity is associated with increased left ventricular mass and reduced ventricular volumes — suggesting concentric ...
Eli Lilly has surpassed analysts’ highest hopes for the efficacy of retatrutide, linking the triple agonist to 28.7% weight ...
Obesity has become a health epidemic! “Approximately 40 percent of the American population is considered overweight or obese, ...
In today’s ACT Brief, we highlight new insights from McKinsey on where AI can meaningfully accelerate clinical development, break down the emerging design and regulatory forces reshaping obesity drug ...
Soybean oil, used for cooking in more than half of American households, is linked to a higher risk of obesity in a new study.
Doctors say the class of medications that includes Ozempic and Zepbound still offers health benefits for people with diabetes ...
A study found soybean oil contributed to obesity in mice, prompting concern about its use as America's most popular cooking ...
Obesity accelerates the rise of Alzheimer’s-related blood biomarkers far more rapidly than previously recognized. Long-term ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback